P3 Health Partners Inc (PIII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 1,459,080 | 1,500,455 | 1,266,375 | 1,049,471 | 637,364 |
| Cost of Goods | 1,519,240 | 1,559,372 | 1,234,740 | 1,057,224 | 659,342 |
| Gross Profit | -60,160 | -58,917 | 31,635 | -7,753 | -21,978 |
| Operating Expenses | 210,381 | 262,113 | 200,305 | 1,553,384 | 166,310 |
| Operating Income | -270,301 | -320,658 | -167,930 | -1,560,913 | -187,946 |
| Interest Expense | 55,034 | 22,173 | 15,985 | 11,404 | 10,675 |
| Other Income | 4,274 | 36,840 | 184 | 12,622 | -5,717 |
| Pre-tax Income | -321,061 | -305,991 | -183,731 | -1,559,695 | -204,338 |
| Income Tax | 2,025 | 4,387 | 2,695 | 1,862 | N/A |
| Net Income Continuous | -323,086 | -310,378 | -186,426 | -1,561,557 | -204,338 |
| Minority Interests | -175,138 | -174,529 | -128,653 | -1,291,430 | -47,857 |
| Net Income | $-147,948 | $-135,849 | $-57,773 | $-270,127 | $-156,481 |
| EPS Basic Total Ops | -45.26 | -46.78 | -30.50 | -325.00 | -12.00 |
| EPS Basic Continuous Ops | -98.83 | -106.88 | -98.23 | -1,877.82 | -245.72 |
| EPS Diluted Total Ops | -45.26 | -54.06 | -31.50 | -325.00 | -12.00 |
| EPS Diluted Continuous Ops | -98.83 | -105.57 | -31.64 | -1,877.82 | -245.72 |
| EPS Diluted Before Non-Recurring Items | N/A | -44.00 | -31.50 | 232.00 | N/A |
| EBITDA(a) | $-172,582 | $-234,513 | $-80,670 | $-158,272 | $-177,424 |